"Jersey Shore University Medical Center is an academic medical center and a regional referral center for complex care, located in Neptune, New Jersey."

During the past decade, Jersey Shore University Medical Center conducted 96 clinical trials. In the 10-year time frame, 96 clinical trials started and 87 clinical trials were completed, i.e. on average, 90.6% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 56 clinical trials were completed. i.e. 164.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jersey Shore University Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 34 trials, followed by "Boston Scientific Corporation" with 9 trials sponsored, "SWOG Cancer Research Network" with 9 trials sponsored, "Abbott Medical Devices" with 8 trials sponsored and "Sunovion" with 8 trials sponsored. Other sponsors include 115 different institutions and companies that sponsored additional 87 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jersey Shore University Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 38 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Rutgers Cancer Institute of New Jersey" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 56 trials.

According to Clinical.Site data, the most researched conditions in "Jersey Shore University Medical Center" are "HIV Infections" (9 trials), "Ovarian Endometrioid Adenocarcinoma" (8 trials), "Ovarian Seromucinous Carcinoma" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials) and "Fallopian Tube Endometrioid Adenocarcinoma" (7 trials). Many other conditions were trialed in "Jersey Shore University Medical Center" in a lesser frequency.

Most popular intervention types in "Jersey Shore University Medical Center" are "Drug" (116 trials), "Other" (61 trials), "Biological" (39 trials), "Device" (39 trials) and "Procedure" (26 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (31 trials), "Quality-of-Life Assessment" (26 trials), "Paclitaxel" (22 trials), "Placebo" (19 trials) and "Carboplatin" (16 trials). Other intervention names were less common.

The vast majority of trials in "Jersey Shore University Medical Center" are 140 trials for "All" genders, 45 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Jersey Shore University Medical Center". undefined are not yet recruiting, 22 are recruiting, 52 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 85 completed trials in Jersey Shore University Medical Center, 3 suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Jersey Shore University Medical Center, 2 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 94 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 30 trials that are defined as “Not Applicable".

Jersey Shore University Medical Center has several departments that took part in Clinical trials: "Hackensack Meridian Health - John Theurer Cancer Center" - 19 trials, "Joseph M. Sanzari Children's Hospital" - 10 trials, "Jersey Shore Cancer Center at Jersey Shore University Medical Center" - 9 trials